Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
University Library
Adelaide Festival of Ideas
Barr Smith Press
Friends of the University of Adelaide Library
Library Publications
Internal documents (Library staff only)
Library images
Library reports and papers
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 121 (Search time: 0.005 seconds).
previous
1
2
3
4
...
13
next
Item hits:
Preview
Issue Date
Title
Author(s)
2002
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation
Mullighan, C.
;
Heatley, S.
;
Doherty, K.
;
Szabo, F.
;
Grigg, A.
;
Hughes, T.
;
Schwarer, A.
;
Szer, J.
;
Tait, B.
;
To, L.
;
Bardy, P.
1995
A direct analysis of FACS-sorted hemopoietic cell fractions using fish
White, D.
;
Hutchins, C.
;
Haylock, D.
;
Turczynowics, S.
;
Bishop, A.
;
To, L.
;
Hughes, T.
;
Juttner, C.
2002
Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant
Frost, M.
;
Ferrao, P.
;
Hughes, T.
;
Ashman, L.
2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
Branford, S.
;
Rudzki, Z.
;
Walsh, S.
;
Grigg, A.
;
Arthur, C.
;
Taylor, K.
;
Herrmann, R.
;
Lynch, K.
;
Hughes, T.
1997
Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control.
Hughes, T.
;
Grigg, A.
;
Szer, J.
;
Ho, J.
;
Ma, D.
;
Dale, B.
;
Green, R.
;
Norman, J.
;
Sage, R.
;
Herrmann, R.
;
Cannell, P.
;
Schwarer, A.
;
Taylor, K.
;
Atkinson, K.
;
Arthur, C.
1998
Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells
Lewis, I.
;
McDiarmid, L.
;
Samels, L.
;
To, L.
;
Hughes, T.
2009
An evaluation of maxillary and mandibular rotational responses with the Clark twin block appliance
Lau, E.
;
Sampson, W.
;
Townsend, G.
;
Hughes, T.
2006
New growth references for assessment of stature and skeletal maturation in Australians
Lin, N.
;
Ranjitkar, S.
;
Macdonald, R.
;
Hughes, T.
;
Taylor, J.
;
Townsend, G.
2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Druker, B.
;
Guilhot, F.
;
O'Brien, S.
;
Gathmann, I.
;
Kantarjian, H.
;
Gattermann, N.
;
Deininger, M.
;
Silver, R.
;
Goldman, J.
;
Stone, R.
;
Cervantes, F.
;
Hochhaus, A.
;
Powell, B.
;
Gabrilove, J.
;
Rousselot, P.
;
Reiffers, J.
;
Cornelissen, J.
;
Hughes, T.
;
Agis, H.
;
Fischer, T.
;
et al.
2017
Reduced CD62L expression on T cells and increased soluble CD62L levels predict molecular response to tyrosine kinase inhibitor therapy in early chronic-phase chronic myelogenous leukemia
Sopper, S.
;
Mustjoki, S.
;
White, D.
;
Hughes, T.
;
Valent, P.
;
Burchert, A.
;
Gjertsen, B.
;
Gastl, G.
;
Baldauf, M.
;
Trajanoski, Z.
;
Giles, F.
;
Hochhaus, A.
;
Ernst, T.
;
Schenk, T.
;
Janssen, J.
;
Ossenkoppele, G.
;
Porkka, K.
;
Wolf, D.
Discover
Author
37
White, D.
29
Branford, S.
24
Hochhaus, A.
14
Radich, J.
14
To, L.
13
Kantarjian, H.
13
Saglio, G.
13
Zannettino, A.
12
Saunders, V.
11
Cortes, J.
.
next >
Subject
41
Protein Kinase Inhibitors
35
Adult
32
Middle Aged
28
Treatment Outcome
24
Aged
19
Dasatinib
19
Drug Resistance, Neoplasm
18
Thiazoles
15
Prognosis
15
Protein-Tyrosine Kinases
.
< previous
next >
Date issued
52
2010 - 2018
65
2000 - 2009
4
1995 - 1999